SPARK Taiwan program kicks off at NCKU - noodls
Tainan, Taiwan, June 19, 2013
"Benefit the society is our responsibility and this is a chance to give back." said Dr. Daria Mochly-Rosen, Senior Associate Dean for Research at Stanford University, who introduced a drug development program at Stanford University during a recent conference held at National Cheng Kung University (NCKU), southern Taiwan.
The launch of SPARK Taiwan program was announced by the university at the press conference, June 14, with over a hundred of domestic and foreign experts gathering to share experiences in academia-industry collaboration. NCKU President Hwung-Hweng Hwung welcomed the guests, "NCKU has committed to help promoting the project initiated by Taiwan's Supra Integration and Incubation Center (Si2C)."
"NCKU has a great experience in interdisciplinary cooperation when the college of Engineering, Medicine, Biotechnology has cooperated with each other for a long period of time," noted President Hwung.
Director of the Stanford SPARK Program Dr. Rosen who currently leads the school's effort in translational research was invited to NCKU to share her experience in leading the SPARK, which is a drug development program at Stanford University School of Medicine in 2006.
"SPARK intends to close the gap between academic discoveries and their development into products that impact human health," according to Dr. Rosen.
fMany academicians are innovators but lack of training and expertise to reduce a promising idea to practice, according to Dr. Rosen. "The value of academic invention is not materialized."
"Apparently, this university has good track of record in med-tech development and also there's an industry park around the university," according to Rosen who added, "the combination of expert and experience and a good track of record in inventionship is very promising.
" Si2C Chief Advisor Soo Whai-jen said that the top priority for the center going forward is to integrate and promote the local biotech sector's R&D capabilities and establish the core infrastructure required to cultivate the industry value chain.
SPARK Taiwan which seeks to cultivate multidisciplinary professionals in high-end medical devices is taken SPARK at Stanford University into account, and NCKU will cooperate with Stanford University to apply its successful patterns of funding, mentorship, training to the developing local biotechnology sectors in Taiwan.
"Benefit the society is our responsibility and this is a chance to give back." said Dr. Daria Mochly-Rosen, Senior Associate Dean for Research at Stanford University, who introduced a drug development program at Stanford University during a recent conference held at National Cheng Kung University (NCKU), southern Taiwan.
The launch of SPARK Taiwan program was announced by the university at the press conference, June 14, with over a hundred of domestic and foreign experts gathering to share experiences in academia-industry collaboration. NCKU President Hwung-Hweng Hwung welcomed the guests, "NCKU has committed to help promoting the project initiated by Taiwan's Supra Integration and Incubation Center (Si2C)."
"NCKU has a great experience in interdisciplinary cooperation when the college of Engineering, Medicine, Biotechnology has cooperated with each other for a long period of time," noted President Hwung.
Director of the Stanford SPARK Program Dr. Rosen who currently leads the school's effort in translational research was invited to NCKU to share her experience in leading the SPARK, which is a drug development program at Stanford University School of Medicine in 2006.
"SPARK intends to close the gap between academic discoveries and their development into products that impact human health," according to Dr. Rosen.
fMany academicians are innovators but lack of training and expertise to reduce a promising idea to practice, according to Dr. Rosen. "The value of academic invention is not materialized."
"Apparently, this university has good track of record in med-tech development and also there's an industry park around the university," according to Rosen who added, "the combination of expert and experience and a good track of record in inventionship is very promising.
" Si2C Chief Advisor Soo Whai-jen said that the top priority for the center going forward is to integrate and promote the local biotech sector's R&D capabilities and establish the core infrastructure required to cultivate the industry value chain.
SPARK Taiwan which seeks to cultivate multidisciplinary professionals in high-end medical devices is taken SPARK at Stanford University into account, and NCKU will cooperate with Stanford University to apply its successful patterns of funding, mentorship, training to the developing local biotechnology sectors in Taiwan.
Click Num:
Share
